Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

Stock Market Today, Aug. 26: Boston Scientific Shares Fall 5% on Cybersecurity Incident and Product Recall

On Aug. 26, 2026, a cyberattack halted order processing and shipping at the medical device maker, leaving investors uncertain about the speed of recovery and near-term shipment delays.

Stock Market Today, Aug. 26: Boston Scientific Shares Fall 5% on Cybersecurity Incident and Product Recall

Published August 26, 2026 · Category: Finance

Overview

Boston Scientific (NYSE:BSX), a global medical device maker, closed at $48.17, down 3.38%. Premarket reports said a cybersecurity incident disrupted global operations and shipping. The company also announced a product recall for certain types of its percutaneous catheters, further weighing on the stock. Investors are watching how quickly the company restores its systems and whether the recall exacerbates the interruption. Trading volume reached 31.8M shares, coming in about 48% above its three-month average of 21.4M shares.

S&P 500 (SNPINDEX:^GSPC) fell 0.04% to 7,675, and the Nasdaq Composite (NASDAQINDEX:^IXIC) slipped 0.08% to 26,130. Among medical devices and interventional medtech peers, Abbott Laboratories (NYSE:ABT) closed at $114.10, down 1.75%, while Medtronic (NYSE:MDT) finished at $92.01, up 0.95%, as Boston Scientific's cyber disruption stood out.

Details

Boston Scientific has seen its stock drop 55% over the last year, and today's double dose of bad news didn't help things. The product recall is tied to the company's ENROUTE Transcarotid Neuroprotection System (NPS) following the FDA's concerns about the potential separation of the product's arterial sheath tip.

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.